Concurrently, elevated expression of the sterol regulatory element-binding transcription factor 1 (SREBF1) protein has been correlated with increased lymph node metastasis and diminished survival rates in IMPC patients, underscoring its potential as a diagnostic and therapeutic biomarker (16). This evidence concerns the gene SREBF1 and metastatic malignant neoplasm in the lymph nodes.